title: Capsule commentary on Turner et al., chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
authors.affiliation: University of California, Davis, Sacramento, CA, 95817, USA, barich@ucdavis.edu.
authors.forename: Ben A
authors.initials: BA
authors.lastname: Rich
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D009293:Opioid-Related Disorders / Q000175:diagnosis* / Q000652:urine*; D040242:Risk Reduction Behavior; D015813:Substance Abuse Detection / Q000639:trends*; D016482:Urinalysis / Q000639:trends*
chemical_list: D000701:Analgesics, Opioid